GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (OTCPK:GENSF) » Definitions » Construction In Progress

Genus (GENSF) Construction In Progress : $18.1 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Genus Construction In Progress?

Genus's quarterly construction in progress increased from Dec. 2022 ($18.9 Mil) to Jun. 2023 ($21.3 Mil) but then declined from Jun. 2023 ($21.3 Mil) to Dec. 2023 ($18.1 Mil).

Genus's annual construction in progress increased from Jun. 2021 ($31.0 Mil) to Jun. 2022 ($36.5 Mil) but then declined from Jun. 2022 ($36.5 Mil) to Jun. 2023 ($21.3 Mil).


Genus Construction In Progress Historical Data

The historical data trend for Genus's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Construction In Progress Chart

Genus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.96 10.26 31.00 36.45 21.34

Genus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.64 36.45 18.88 21.34 18.10

Genus Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Genus (GENSF) Business Description

Traded in Other Exchanges
Address
Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.